| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5537385 | Vaccine | 2017 | 8 Pages |
Abstract
Thus, this innovative approach is better suited to rationally engineer and mass produce influenza CVV within significantly shorter timelines to enable an effective global response in pandemic situations.
Keywords
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Ernest Milián, Thomas Julien, Rafael Biaggio, Alina Venereo-Sanchez, Johnny Montes, Aziza P. Manceur, Sven Ansorge, Emma Petiot, Manuel Rosa-Calatrava, Amine Kamen,